Clinical Trial Results: Pain; Bone Neoplasms; Neoplasm Metastasis

Product Name: Bondronat [Ibandronate]
Date of Report: 10/1/2004
Phase: III
Infusion of 4mg or 6mg Ibandronate in patients with breast cancer and bone metastases

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: IV
A Study to Assess the Efficacy of Oral Bondronat (ibandronate) in Patients with Metastatic Bone Disease due to Breast Cancer

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: II
A Study of Bondronat (Ibandronate) in Patients With Metastatic Bone Disease

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: III
A Study to Evaluate Renal Safety of Intravenous Bondronat (Ibandronate) in Patients With Metastatic Bone Disease due to Breast Cancer

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: II
A Study of Bondronat (Ibandronate) in Patients With Metastatic Bone Disease From Breast Cancer or Multiple Myeloma.

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: IV
A Study to Assess the Short Term Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Metastatic Bone Pain due to Breast Cancer.

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: II
A Study of Bondronat (Ibandronate) in Elderly Patients With Bone Metastases.

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: III
A Study of Bondronat (Ibandronate) in Patients With Metastatic Bone Disease.

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: II
A Study of Intravenous Bondronat (Ibandronate) in Patients WIth Bone Metastases due to Prostatic Cancer.

Product Name: Bondronat [ibandronate]
Date of Report: 10/2/2006
Phase: II
Prospective, multicenter study to evaluate the renal safety of 6 mg ibandronic acid infusions over 15 min or 60 min in patients with metastatic bone disease due to breast cancer

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: II
A Study of Load-Dose Intravenous Bondronat (Ibandronate) on Bone Pain in Patients With Breast Cancer and Metastatic Bone Disease.

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: III
A Study of Bondronat (Ibandronate) in Patients With Malignant Bone Disease.

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: II
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

Product Name: Bondronat [ibandronate]
Date of Report: To be Published
Phase: II
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

Product Name: Bondronat [ibandronate]
Date of Report: 10/1/2007
Phase: III
A randomized, two arm, placebo controlled study to compare the efficacy of intravenous loading doses followed by maintenance treatment with oral ibandronic acid versus zoledronic acid in patients with skeletal metastases experiencing moderate to severe pain.

Product Name: Bondronat [ibandronate]
Date of Report: 10/1/2007
Phase: III
A randomized, two arm, placebo controlled study to compare the efficacy of intravenous loading doses followed by maintenance treatment with intravenous ibandronic acid versus zoledronic acid patients with skeletal metastases experiencing moderate to severe pain.

Product Name: Bondronat [ibandronate]
Date of Report: 12/19/2007
Phase: IV
PREFERENCE study - A Study of Oral and Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis